These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 27671847)

  • 1. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
    Davies LC; Heldring N; Kadri N; Le Blanc K
    Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
    Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
    J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
    Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
    Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
    Strauch V; Saul D; Berisha M; Mackensen A; Mougiakakos D; Jitschin R
    Stem Cells; 2020 Aug; 38(8):986-993. PubMed ID: 32346937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.
    Kinter AL; Godbout EJ; McNally JP; Sereti I; Roby GA; O'Shea MA; Fauci AS
    J Immunol; 2008 Nov; 181(10):6738-46. PubMed ID: 18981091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions.
    Yan Z; Zhuansun Y; Liu G; Chen R; Li J; Ran P
    Immunol Lett; 2014 Nov; 162(1 Pt A):248-55. PubMed ID: 25281059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly I:C primes the suppressive function of human palatine tonsil-derived MSCs against Th17 differentiation by increasing PD-L1 expression.
    Cho KA; Park M; Kim YH; Ryu KH; Woo SY
    Immunobiology; 2017 Feb; 222(2):394-398. PubMed ID: 27594385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cells Upregulate the Expression of PD-L1 But Not VDR in Dendritic Cells.
    Moravej A; Karimi MH; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Khosravi M; Kalani M; Gharesi-Fard B
    Immunol Invest; 2017 Jan; 46(1):80-96. PubMed ID: 27736253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PD-1 with PD-L1 Axis Is Pertinent with the Immune Modulation of Atrial Fibrillation by Regulating T Cell Excitation and Promoting the Secretion of Inflammatory Factors.
    Chang G; Chen Y; Liu Z; Wang Y; Ge W; Kang Y; Guo S
    J Immunol Res; 2022; 2022():3647817. PubMed ID: 35600045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease
    Hackel A; Vollmer S; Bruderek K; Lang S; Brandau S
    Front Immunol; 2023; 14():1078551. PubMed ID: 36875112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immunomodulatory Effect of Triptolide on Mesenchymal Stromal Cells.
    He H; Takahashi A; Mukai T; Hori A; Narita M; Tojo A; Yang T; Nagamura-Inoue T
    Front Immunol; 2021; 12():686356. PubMed ID: 34484183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells.
    Yang M; Liu P; Wang K; Glorieux C; Hu Y; Wen S; Jiang W; Huang P
    Mol Oncol; 2017 Apr; 11(4):358-372. PubMed ID: 28218497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of interferon-γ on human fetal cardiac mesenchymal stromal cells.
    Grinnemo KH; Löfling M; Nathanson L; Baumgartner R; Ketelhuth DFJ; Beljanski V; Davies LC; Österholm C
    Stem Cell Res Ther; 2019 Dec; 10(1):371. PubMed ID: 31801632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
    Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
    Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.